Skip to content

Feasibility of a neuromuscular electrostimulation device for mechanical thromboprophylaxis in ICU patients

Feasibility of a neuromuscular electrostimulation device for mechanical thromboprophylaxis in ICU patients - geko in ICU patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015841
Enrollment
100
Registered
2018-11-02
Start date
2019-03-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I74.3

Interventions

Group 1: group 1: thromboprophylaxis = low molecular weight Heparin (LMWH) + intermittent pneumatic compression (IPC) study associated procedures: daily questionaire regarding feasibility + compressi

Sponsors

Medizinische Universität Wien
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: age = 18 years, Caprini Score = 5 indicating the highest risk of VTE and therefore combined VTE prophylaxis (Enoxaparin 1x40mg + mechanical device)

Exclusion criteria

Exclusion criteria: patient`s refusal of participation, neuromuscular disorder of the lower limbs, formally prohibition of muscle movement in the lower limb (e.g. after certain surgical procedures), implanted electronic devices (e.g. pacemaker), recently diagnosed or suspected thromboembolic event (especially DVT), local open wound or cancerous lesion, pregnancy, epilepsy

Design outcomes

Primary

MeasureTime frame
feasibility, Duration of use of the mechanical device per day

Secondary

MeasureTime frame
patient compliance, patient comfort, satisfaction of the health care team concerning handling, incidence of procedural problems, costs, incidence of thromboembolic events

Countries

Austria

Contacts

Public ContactMarion Wiegele

Medizinische Universität Wien

marion.wiegele@meduniwien.ac.at+43-1-40400/6820

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026